Oncology Institute Operating Margin 2020-2025 | TOI
Current and historical operating margin for Oncology Institute (TOI) over the last 10 years. The current operating profit margin for Oncology Institute as of September 30, 2025 is -12.64%.
| Oncology Institute Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $0.46B | $-0.04B | -8.89% |
| 2025-06-30 | $0.42B | $-0.05B | -11.08% |
| 2025-03-31 | $0.40B | $-0.05B | -12.90% |
| 2024-12-31 | $0.39B | $-0.06B | -15.23% |
| 2024-09-30 | $0.38B | $-0.06B | -16.58% |
| 2024-06-30 | $0.36B | $-0.06B | -17.40% |
| 2024-03-31 | $0.34B | $-0.06B | -18.08% |
| 2023-12-31 | $0.32B | $-0.08B | -23.77% |
| 2023-09-30 | $0.31B | $-0.09B | -28.16% |
| 2023-06-30 | $0.29B | $-0.09B | -31.85% |
| 2023-03-31 | $0.27B | $-0.10B | -35.16% |
| 2022-12-31 | $0.25B | $-0.08B | -32.14% |
| 2022-09-30 | $0.23B | $-0.10B | -41.63% |
| 2022-06-30 | $0.22B | $-0.08B | -35.91% |
| 2022-03-31 | $0.21B | $-0.06B | -29.67% |
| 2021-12-31 | $0.20B | $-0.05B | -22.66% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.328B | $0.393B |
| The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $165.999B | 30.48 |
| HCA Healthcare (HCA) | United States | $107.452B | 17.79 |
| CVS Health (CVS) | United States | $105.376B | 12.12 |
| Elevance Health (ELV) | United States | $82.464B | 12.09 |
| Cencora (COR) | United States | $68.573B | 22.11 |
| Natera (NTRA) | United States | $33.416B | 0.00 |
| DiDi Global (DIDIY) | China | $23.344B | 21.57 |
| Labcorp Holdings (LH) | United States | $22.106B | 16.86 |
| Medpace Holdings (MEDP) | United States | $16.564B | 41.12 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.437B | 0.00 |
| Viatris (VTRS) | United States | $15.215B | 5.67 |
| ICON (ICLR) | Ireland | $15.077B | 14.96 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.687B | 13.28 |
| Revvity (RVTY) | United States | $13.234B | 24.37 |
| CochLear (CHEOY) | Australia | $12.390B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.808B | 20.82 |
| Avantor (AVTR) | United States | $8.045B | 12.29 |
| Sonic Healthcare (SKHHY) | Australia | $7.967B | 0.00 |
| HealthEquity (HQY) | United States | $7.186B | 26.87 |
| BrightSpring Health Services (BTSG) | United States | $7.149B | 42.62 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.054B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.014B | 39.49 |
| PACS (PACS) | United States | $5.477B | 33.30 |
| Sotera Health (SHC) | United States | $5.259B | 25.36 |
| Alignment Healthcare (ALHC) | United States | $4.764B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.930B | 51.45 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.537B | 2.67 |
| Progyny (PGNY) | United States | $2.174B | 42.75 |
| Surgery Partners (SGRY) | United States | $2.088B | 26.90 |
| Establishment Labs Holdings (ESTA) | United States | $1.916B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.850B | 11.05 |
| Ardent Health (ARDT) | United States | $1.226B | 4.00 |
| Teladoc Health (TDOC) | United States | $1.123B | 0.00 |
| Nutex Health (NUTX) | United States | $1.105B | 8.45 |
| CareDx (CDNA) | United States | $1.050B | 17.16 |
| Omada Health (OMDA) | United States | $0.957B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.869B | 14.22 |
| InnovAge Holding (INNV) | United States | $0.791B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.688B | 0.00 |
| Embecta (EMBC) | United States | $0.648B | 3.68 |
| Sonida Senior Living (SNDA) | United States | $0.592B | 0.00 |
| Enhabit (EHAB) | United States | $0.546B | 24.52 |
| CryoPort (CYRX) | United States | $0.520B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.472B | 0.00 |
| SBC Medicals (SBC) | United States | $0.448B | 8.25 |
| Auna S.A (AUNA) | Luxembourg | $0.419B | 6.74 |
| Agilon Health (AGL) | United States | $0.411B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.320B | 67.24 |
| Shoulder Innovations (SI) | United States | $0.307B | 0.00 |
| So-Young (SY) | China | $0.291B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| KindlyMD (NAKA) | United States | $0.177B | 0.00 |
| LifeMD (LFMD) | United States | $0.172B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.135B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.125B | 0.00 |
| Biodesix (BDSX) | United States | $0.093B | 0.00 |
| DocGo (DCGO) | United States | $0.082B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| Pomdoctor - (POM) | China | $0.029B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.41 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |